Why Jeff Geschwind, MD is a Oncology Visionary Jeff Geschwind, MD merges drug development, imaging tech, and interventional therapies to redefine cancer care—proving why he’s a trailblazer in modern oncology. https://www.onclive.com/authors/jeff-geschwind-md-johns-hopkins